BR0103887C1 - Immunogenic compositions containing biodegradable microspheres encapsulating antigens, gene vectors and adjuvants - Google Patents
Immunogenic compositions containing biodegradable microspheres encapsulating antigens, gene vectors and adjuvantsInfo
- Publication number
- BR0103887C1 BR0103887C1 BR0103887-7A BR0103887A BR0103887C1 BR 0103887 C1 BR0103887 C1 BR 0103887C1 BR 0103887 A BR0103887 A BR 0103887A BR 0103887 C1 BR0103887 C1 BR 0103887C1
- Authority
- BR
- Brazil
- Prior art keywords
- antigens
- compositions containing
- immunogenic compositions
- adjuvants
- microspheres
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
"COMPOSIçõES IMUNOGêNICAS CONTENDO MICROESFERAS BIODEGRADáVEIS ENCAPSULANDO ANTìGENOS, VETORES GêNICOS E ADJUVANTES". A presente invenção diz respeito a composições capazes de estimular uma resposta imune em um hospedeiro inoculado com um antígeno de interesse ou o vetor gênico que o codifica, onde dita composição compreende microesferas baseadas em copolímeros derivados do ácido lático e do ácido glicólico encapsulando antígenos, vetores gênicos e/ou adjuvantes estimuladores da resposta imune obtidos de frações de micobactérias. Uma concretização da presente invenção é o uso do dimicolato de trealose associado a uma proteína de choque térmico ou ao plasmídeo contendo o gene que a codifica encapsulados em microesferas com um tamanho de partícula inferior a 10 <109>m, capaz de induzir a secreção de citocinas implicadas na proteção de doenças infecciosas, após administração de uma única dose ou várias doses."IMMUNOGENIC COMPOSITIONS CONTAINING BIODEGRADABLE MICROSPHERES INCREASING ANTIGENS, GENE AND ADJUVANT VECTORS". The present invention relates to compositions capable of stimulating an immune response in a host inoculated with an antigen of interest or the encoding gene vector, wherein said composition comprises microspheres based on copolymers derived from lactic acid and glycolic acid encapsulating antigens, vectors. and / or immune response stimulating adjuvants obtained from mycobacterial fractions. One embodiment of the present invention is the use of trehalose dimicolate associated with a heat shock protein or plasmid containing the encoding gene encapsulated in microspheres with a particle size of less than 10 µm capable of inducing secretion of cytokines implicated in the protection of infectious diseases following single or multiple doses.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0103887-7A BR0103887C1 (en) | 2001-07-17 | 2001-07-17 | Immunogenic compositions containing biodegradable microspheres encapsulating antigens, gene vectors and adjuvants |
EP02744957A EP1420823A2 (en) | 2001-07-17 | 2002-07-17 | Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
PCT/BR2002/000099 WO2003007869A2 (en) | 2001-07-17 | 2002-07-17 | Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
CNA028171861A CN1549728A (en) | 2001-07-17 | 2002-07-17 | Immune composition containing antigen, gene vector and adjuvant |
AU2002317056A AU2002317056A1 (en) | 2001-07-17 | 2002-07-17 | Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
CA002453959A CA2453959A1 (en) | 2001-07-17 | 2002-07-17 | Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0103887-7A BR0103887C1 (en) | 2001-07-17 | 2001-07-17 | Immunogenic compositions containing biodegradable microspheres encapsulating antigens, gene vectors and adjuvants |
Publications (2)
Publication Number | Publication Date |
---|---|
BR0103887A BR0103887A (en) | 2003-08-05 |
BR0103887C1 true BR0103887C1 (en) | 2005-11-08 |
Family
ID=3947962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0103887-7A BR0103887C1 (en) | 2001-07-17 | 2001-07-17 | Immunogenic compositions containing biodegradable microspheres encapsulating antigens, gene vectors and adjuvants |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1420823A2 (en) |
CN (1) | CN1549728A (en) |
BR (1) | BR0103887C1 (en) |
CA (1) | CA2453959A1 (en) |
WO (1) | WO2003007869A2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9492400B2 (en) | 2004-11-04 | 2016-11-15 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
CN1317560C (en) * | 2005-10-19 | 2007-05-23 | 华中科技大学 | Method for increasing coding stability of quantum point coding microball |
US9267937B2 (en) | 2005-12-15 | 2016-02-23 | Massachusetts Institute Of Technology | System for screening particles |
EP2007435B1 (en) | 2006-03-31 | 2019-12-18 | Massachusetts Institute Of Technology | System for targeted delivery of therapeutic agents |
CA2652280C (en) | 2006-05-15 | 2014-01-28 | Massachusetts Institute Of Technology | Polymers for functional particles |
WO2007150030A2 (en) | 2006-06-23 | 2007-12-27 | Massachusetts Institute Of Technology | Microfluidic synthesis of organic nanoparticles |
WO2008098165A2 (en) | 2007-02-09 | 2008-08-14 | Massachusetts Institute Of Technology | Oscillating cell culture bioreactor |
WO2008124632A1 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Amphiphilic compound assisted nanoparticles for targeted delivery |
JP2011500569A (en) | 2007-10-12 | 2011-01-06 | マサチューセッツ インスティテュート オブ テクノロジー | Vaccine nanotechnology |
CN101376023B (en) * | 2008-10-10 | 2011-12-28 | 山西海森生物制品有限公司 | Vaccine sustained-release agent for birds as well as preparation and inoculation method thereof |
US8343498B2 (en) | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
US8591905B2 (en) | 2008-10-12 | 2013-11-26 | The Brigham And Women's Hospital, Inc. | Nicotine immunonanotherapeutics |
US8343497B2 (en) | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
US8277812B2 (en) | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
LT2661253T (en) * | 2011-01-04 | 2017-05-25 | Archivel Farma, Sl | Liposome formulation suitable for treating or preventing tuberculosis |
IN2014MN01594A (en) | 2012-01-12 | 2015-05-08 | Archivel Farma Sl | |
AU2013318338B2 (en) | 2012-09-21 | 2017-05-25 | Intensity Therapeutics, Inc | Method of treating cancer |
EP3142852B1 (en) | 2014-05-14 | 2021-12-01 | Dicar, Inc. | Protective cover including patterned backings |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01207237A (en) * | 1988-02-15 | 1989-08-21 | Sawai Seiyaku Kk | Tumor necrosis factor inducer |
US6048551A (en) * | 1997-03-27 | 2000-04-11 | Hilfinger; John M. | Microsphere encapsulation of gene transfer vectors |
-
2001
- 2001-07-17 BR BR0103887-7A patent/BR0103887C1/en not_active IP Right Cessation
-
2002
- 2002-07-17 CN CNA028171861A patent/CN1549728A/en active Pending
- 2002-07-17 EP EP02744957A patent/EP1420823A2/en not_active Withdrawn
- 2002-07-17 CA CA002453959A patent/CA2453959A1/en not_active Abandoned
- 2002-07-17 WO PCT/BR2002/000099 patent/WO2003007869A2/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
BR0103887A (en) | 2003-08-05 |
EP1420823A2 (en) | 2004-05-26 |
CA2453959A1 (en) | 2003-01-30 |
CN1549728A (en) | 2004-11-24 |
WO2003007869A2 (en) | 2003-01-30 |
WO2003007869A3 (en) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0103887C1 (en) | Immunogenic compositions containing biodegradable microspheres encapsulating antigens, gene vectors and adjuvants | |
Rodriguez et al. | Control of Boophilus microplus populations in grazing cattle vaccinated with a recombinant Bm86 antigen preparation | |
Delaney et al. | A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice | |
BR0208301A (en) | Nucleic Acid Vaccines for Preventing Flavivirus Infection | |
BRPI0007936B8 (en) | compound, immunological adjuvant formulation, and vaccine formulation. | |
WO2003011223A3 (en) | Immunomodulatory compounds and methods of use thereof | |
HK1121382A1 (en) | Adjuvant compositions for enhancing immune responses to polynucleotide- based vaccines | |
HK1110769A1 (en) | Immunological compositions and vaccines containing n-formyl methionyl peptide as adjuvant | |
CA2448208A1 (en) | Influenza vaccine composition | |
AU3526995A (en) | Vaccine compositions | |
BRPI0512421A (en) | avipox recombinants expressing foot-and-mouth disease virus genes | |
WO2001045639A3 (en) | Methods for protecting against lethal infection with bacillus anthracis | |
HUP0500238A2 (en) | Interleukin-12 as a veterinary vaccine adjuvant | |
AU1813701A (en) | Interleukin-1 muteins useful as vaccine adjuvants | |
Ghasemi et al. | Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in mice | |
ATE275421T1 (en) | VACCINES CONTAINING INTERLEUKIN-12 AND HERPES SIMPLEX VIRUS ANTIGEN | |
WO2015138471A1 (en) | Heat inactivated poxvirus improves vaccination results | |
CA2086097A1 (en) | Adjuvants and vaccines | |
Confer et al. | Serum antibody responses of cattle vaccinated with partially purified native Pasteurella haemolytica leukotoxin | |
RU2009139262A (en) | IMPROVED VACCINES AGAINST BORDETELLA PERTUSSIS BASED ON MUTANT GLYCOSYL TRANSFERASES LPS | |
HK1025220A1 (en) | Novel saponin compositions and uses thereof | |
WO2001035993A3 (en) | Compositions and methods for stimulating an immune response against infectious agents | |
FR2809960B1 (en) | ADJUVANT COMPOSITION OF THE IMMUNE RESPONSE COMPRISING FHA PROTEIN OR A FRAGMENT OF FHA PROTEIN IN FREE FORM, AND IMMUNOGENIC OR VACCINE COMPOSITION CONTAINING SUCH ADJUVANT COMPOSITION | |
BR0013574A (en) | Old Moraxella Vaccine | |
WO1999022763A3 (en) | Encapsulated immunomodulators useful as vaccine adjuvants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B03H | Publication of an application: rectification [chapter 3.8 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE A RPI 1818 DE 08/11/2005 QUANTO AO ITEM (22). |
|
B25A | Requested transfer of rights approved |
Owner name: UNIVERSIDADE FEDERAL DE MINAS GERAIS (BR/MG) , UNI Free format text: TRANSFERIDO DE: CELIO LOPES SILVA Owner name: UNIVERSIDADE FEDERAL DE MINAS GERAIS (BR/MG) , UNI Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: TRANSFERIDO DE: CELIO LOPES SILVA |
|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE A 6A , 7A E 8A ANUIDADES. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE AO DESPACHO PUBLICADO NA RPI 2012 DE 28/07/2009 POR TER SIDO INDEVIDO. |
|
B03H | Publication of an application: rectification [chapter 3.8 patent gazette] |
Free format text: REFERENTE A RPI 1700 DE 05/08/2003, QUANTO AO ITEM (72). Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE A RPI 1818 DE 08/11/2005, QUANTO AO ITEM (72). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE AO DESPACHO 8.11 DA RPI 2072 DE 21/09/2010. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B15V | Prolongation of time limit allowed |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 20 (VINTE) DIAS, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04. Free format text: RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 20 (VINTE) DIAS, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04. |
|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE A 10A E 11A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2156 DE 02/05/2012. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2178 DE 02/10/2012. |
|
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B08G | Application fees: restoration [chapter 8.7 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/01/2019, OBSERVADAS AS CONDICOES LEGAIS. |
|
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 19A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2594 DE 24-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B11Q | Dismissal: the certificate of addition was not accessory to any patent, or a patent which was nominated accessory and no longer exists |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: ARQUIVADO O PEDIDO DE CERTIFICADO DE ADICAO DE INVENCAO EM FUNCAO DA EXTINCAO DA PATENTE PRINCIPAL CONFORME PUBLICADO NA RPI 2594, DE 24/09/2020, E DA MANUTENCAO DA EXTINCAO DA PATENTE PRINCIPAL PUBLICADA NA RPI 2610, DE 12/01/2021. |
|
B11T | Dismissal: dismissal of application maintained |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |